Newsletter | January 14, 2026

01.14.26 -- The Rise Of Antimicrobial Resistance And Strategic Research Imperatives

SPONSOR

Webinar: Embedding AI and Critical IRB Operations Data to Drive Intelligent Study Design

Study design is increasingly empowered by a rich and diverse array of data. New sources continue to emerge, fueled by advances in AI that enable the integration of information from literature, ClinicalTrials.gov, digitized protocols, and beyond. Join us for a dynamic discussion on how to critically evaluate and integrate these data streams into study design decisions. Click here to learn more.

DECENTRALIZED TRIALS

Can't-Miss Advice On Selecting Your First AI-Enabled Vendor

Quarles & Brady's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.

The True ROI Of Decentralized Clinical Trials

Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI.

TRIAL MANAGEMENT

The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026

Antimicrobial resistance (AMR) has increasingly worried public health officials and researchers alike in 2025. Now, in 2026, TAXI Pharmaceutical President and CEO Gregory G. Mario, MBA, is calling for more targeted approaches and the integration of AI for quicker discovery and development.

Health Economics And Outcomes Research (HEOR) Explained

Discover how evidence-based frameworks evaluate treatment value, supporting informed decisions that balance patient outcomes with the realities of limited resources.

Biotech Success In Late-Stage Execution

Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences, explores the methodology behind the operating company’s role in the clinical trial industry.

ESMO Congress 2025: Highlights From Berlin

Turn the insights from last year’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration.

Making Good Clinical Practice More Understandable

What role does Good Clinical Practice (GCP) play in the clinical research ecosystem, and how does it safeguard participant rights, safety, and confidentiality while fostering compliance?

Advances In Platforms, Modalities, And Delivery Systems

Examine the treatment landscape for rare diseases and the rapid evolution of gene therapy across three key dimensions: editing platforms, delivery modalities, and delivery vehicles.

Checklist For Risk Management In Document Reviews

Learn how medical writers support effective product development by managing collaboration risks and maintaining quality using tools like document review systems in regulatory submissions.

Global Vaccine Clinical Trials: Australia's Strategic Advantage

The global vaccine clinical trials landscape presents unprecedented opportunities. This report analyses emerging trends, regional opportunities, and Australia’s distinctive strengths in vaccine development.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: